CAS 2143096-93-7 występuje w naszej ofercie pod nazwami: Navitoclax-piperazine/ 99.11% (existing batch purity), Navitoclax–piperazine, Navitoclax-piperazine, Navitoclax-piperazine, 99.73%, (R)-4-(4-((4'-Chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((1-(phenylthio)-4-(piperazin-1-yl)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)benzamide. Oferty producentów: TargetMol, GLPBio, Biosynth, MedChemExpress, Chemat. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 2mg, 10mM/1mL.
4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-1-phenylsulfanyl-4-piperazin-1-ylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide (CAS 2143096-93-7) to związek chemiczny o wzorze sumarycznym C47H56ClF3N6O5S3 i masie molowej 973.6 g/mol. Nazwa systematyczna IUPAC: 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-1-phenylsulfanyl-4-piperazin-1-ylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide. InChIKey: CRPNZDFOWRFBLZ-KXQOOQHDSA-N.
| Wzór sumaryczny | C47H56ClF3N6O5S3 |
|---|---|
| Masa molowa | 973.6 g/mol |
| Nazwa IUPAC | 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-1-phenylsulfanyl-4-piperazin-1-ylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide |
| InChIKey | CRPNZDFOWRFBLZ-KXQOOQHDSA-N |
| SMILES | CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)N[C@H](CCN5CCNCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C |
Dane obliczone przez PubChem (NCBI)